February 1987

Cancer and Venous Thromboembolism

Author Affiliations

Department of Medicine; Department of Preventive Medicine and Clinical Epidemiology; Departments of Medicine and Preventive Medicine and Clinical Epidemiology Brigham and Women's Hospital Harvard Medical School Boston, MA 02115

Arch Intern Med. 1987;147(2):216. doi:10.1001/archinte.1987.00370020036030

Previous case reports, autopsy series, and another cohort study1 have demonstrated a clinically important and statistically significant association between occult cancer and pulmonary embolism. The study by Goldberg et al2 extends this finding to a far more common clinical condition than pulmonary embolism, namely, deep venous thrombosis (DVT). In this study, 370 patients with DVT (diagnosed by impedance plethysmography [IPG]) who did not have overt cancer were compared with 1073 patients suspected of DVT but who had normal IPGs (and no overt cancer). During five years of follow-up, of those with DVT, 6.3% developed cancer, compared with 2.4% of those who had negative IPGs. Thus, in the population that was investigated, the relative risk for developing cancer in the presence of DVT was 2.7, with 95% confidence limits from 1.5 to 4.7. The most frequent sites of cancer were lung and colon, and the majority developed within two

First Page Preview View Large
First page PDF preview
First page PDF preview